Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 31 Aug 2026 for Editas Medicine, Inc., €1,977.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Burkly Linda: trading record in brief
All filings by Burkly Linda on record concern Editas Medicine, Inc. In total, 2 filings cover trades dated from 21 July 2026 to 31 August 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 31 August 2026: a transaction of €1,977, in Editas Medicine, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Burkly Linda
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
700 shares@ US$3.28Common StockSEC144:0001650664-26-000085
5,500 shares@ US$2.880.0036% mcap14.5% of flowCommon StockSEC144:0001650664-26-000074
2 of 2 declarations
